These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 228304
1. Sodium transport inhibitor from bovine hypothalamus. Haupert GT, Sancho JM. Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4658-60. PubMed ID: 228304 [Abstract] [Full Text] [Related]
2. Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system. Akagawa K, Hara N, Tsukada Y. J Neurochem; 1984 Mar; 42(3):775-80. PubMed ID: 6319608 [Abstract] [Full Text] [Related]
5. [Purification of an endogenous inhibitor of sodium-potassium-ATPase]. Cloix JF, Miller ED, Pernollet MG, Devynck MA, Meyer P. C R Seances Acad Sci III; 1983 Feb 07; 296(5):213-6. PubMed ID: 6303528 [Abstract] [Full Text] [Related]
6. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus. Hallaq HA, Haupert GT. Proc Natl Acad Sci U S A; 1989 Dec 07; 86(24):10080-4. PubMed ID: 2557617 [Abstract] [Full Text] [Related]
9. Na+ pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus. Cantiello HF, Chen E, Ray S, Haupert GT. Am J Physiol; 1988 Oct 07; 255(4 Pt 2):F574-80. PubMed ID: 2845805 [Abstract] [Full Text] [Related]
10. [(NA++K+)-ATPase inhibitor from bovine hypothalamus]. Fu Y. Zhonghua Yi Xue Za Zhi; 1990 Aug 07; 70(8):442-5, 32. PubMed ID: 2174283 [Abstract] [Full Text] [Related]
11. Regulation of Na+, K+-ATPase by the endogenous sodium transport inhibitor from hypothalamus. Haupert GT. Hypertension; 1987 Nov 07; 10(5 Pt 2):I61-6. PubMed ID: 2824368 [Abstract] [Full Text] [Related]
14. Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells. Morgan K, Lewis MD, Spurlock G, Collins PA, Foord SM, Southgate K, Scanlon MF, Mir MA. J Biol Chem; 1985 Nov 05; 260(25):13595-600. PubMed ID: 2997173 [Abstract] [Full Text] [Related]
15. Release of an active sodium transport inhibitor (ASTI) from rat hypothalamic cells in culture. Morgan K, Foord SM, Spurlock G, Charalambous BM, Dieguez C, Scanlon MF, Mir MA. Endocrinology; 1984 Oct 05; 115(4):1642-4. PubMed ID: 6148236 [Abstract] [Full Text] [Related]
16. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain. Sancho JM. Clin Exp Hypertens; 1998 Oct 05; 20(5-6):535-42. PubMed ID: 9682909 [Abstract] [Full Text] [Related]
17. Properties of the purified hypothalamic pituitary NA/K-ATPase inhibitor. Sancho JM, Garcia-Martin E, Garcia-Robles R, Santirso R, Villa E, Gutierrez-Merino C, Ricote M. J Cardiovasc Pharmacol; 1993 Oct 05; 22 Suppl 2():S32-4. PubMed ID: 7508022 [Abstract] [Full Text] [Related]
18. Ouabainlike factor in Milan hypertensive rats. Ferrandi M, Minotti E, Salardi S, Florio M, Bianchi G, Ferrari P. Am J Physiol; 1992 Oct 05; 263(4 Pt 2):F739-48. PubMed ID: 1329560 [Abstract] [Full Text] [Related]
19. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine. Clarkson EM, de Wardener HE. Clin Exp Hypertens A; 1985 Oct 05; 7(5-6):673-83. PubMed ID: 2990768 [Abstract] [Full Text] [Related]
20. Franz Volhard Lecture 1996. Sodium transport inhibitors and hypertension. de Wardener HE. J Hypertens Suppl; 1996 Dec 05; 14(5):S9-18. PubMed ID: 9120690 [Abstract] [Full Text] [Related] Page: [Next] [New Search]